CommercialFebruary 1, 2024
Claims match enhancement for Carelon Medical Benefits Management, Inc. Genetic Testing
As part of our ongoing quality improvement efforts, we will be implementing a new Genetic Testing (GT) claim to authorization match enhancement that will ensure GT panels billed have a corresponding authorization. This enhanced match logic will be effective by May 1, 2024. Labs that bill panels with codes in excess of what has been authorized may receive a full claim denial. The goal of this enhanced match logic is to ensure tests performed are authorized and meet medical necessity requirements.
Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan.
Services provided by Empire HealthChoice HMO, Inc. and/or Empire HealthChoice Assurance, Inc., licensees of the Blue Cross Blue Shield Association, an association of independent Blue Cross and Blue Shield plans.
NYBCBS-CM-047629-23-CPN47301
PUBLICATIONS: February 2024 Provider Newsletter
To view this article online:
Or scan this QR code with your phone